January 2010 in “Chinese Journal of Hospital Pharmacy” This study found that finasteride test and reference tablets are bioequivalent in healthy male volunteers, with no significant differences in their pharmacokinetic parameters.
January 2005 in “Zhōnghuá yàoxué zázhì” This study concluded that two different finasteride tablet formulations are bioequivalent based on their pharmacokinetic profiles in a crossover trial with male subjects.
January 2012 in “Pharmacy Today” This study concluded that two formulations of finasteride were bioequivalent based on Cmax, AUC, and Tmax data from healthy volunteers.
This study concluded that domestic and imported finasteride tablets are bioequivalent, showing no significant differences in pharmacokinetic parameters among healthy volunteers.
3 citations
,
November 2022 in “European Journal of Human Genetics” This study developed new genetic prediction models for male pattern baldness with improved accuracy by utilizing a large set of markers and independent datasets, making them the most reliable available for this trait.